CVS HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.15 USD | -2.06% |
|
-18.09% | -30.15% |
| May. 02 | Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing | MT |
| May. 02 | Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77 | MT |
Financials (USD)
| Sales 2024 * | 369B | Sales 2025 * | 390B | Capitalization | 69.23B |
|---|---|---|---|---|---|
| Net income 2024 * | 8.03B | Net income 2025 * | 9.15B | EV / Sales 2024 * | 0.32 x |
| Net Debt 2024 * | 50.23B | Net Debt 2025 * | 44.36B | EV / Sales 2025 * | 0.29 x |
| P/E ratio 2024 * |
9.15
x | P/E ratio 2025 * |
7.83
x | Employees | 259,500 |
| Yield 2024 * |
4.76% | Yield 2025 * |
4.93% | Free-Float | 72.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | +0.16% | ||
| 1 week | -18.09% | ||
| Current month | -18.55% | ||
| 1 month | -25.29% | ||
| 3 months | -24.55% | ||
| 6 months | -20.81% | ||
| Current year | -30.15% |
1 week
53.70
68.19
1 month
53.7075.27
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
51.72111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
David Falkowski
CMP | Compliance Officer | - | 11-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 18 M€ | +3.01% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 55.15 | -2.06% | 37,885,245 |
| 24-05-01 | 56.31 | -16.84% | 65,769,862 |
| 24-04-30 | 67.71 | +0.39% | 13,488,466 |
| 24-04-29 | 67.45 | +0.40% | 6,556,349 |
| 24-04-26 | 67.18 | -0.22% | 6,396,438 |
Delayed Quote Nyse, May 02, 2024 at 04:00 pm EDT
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
2024-05-16
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
55.15
USD
Average target price
76.89
USD
Spread / Average Target
+39.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.15% | 70.69B | |
| +14.10% | 81.84B | |
| +9.37% | 29.03B | |
| -11.90% | 16.97B | |
| -0.36% | 16.83B | |
| -1.12% | 15.28B | |
| +5.90% | 12.41B | |
| +35.78% | 12.26B | |
| -4.20% | 11.86B | |
| -31.05% | 11.83B |
- Stock Market
- Equities
- CVS Stock
